Vaccines by Chinese firms Sinovac Biotech and Sinopharm are being evaluated by the WHO for emergency-use licensing. A decision is expected this week. Photo: Xinhua
Coronavirus: fuller picture of Chinese vaccine data but WHO group finds figures lacking for over 60s
- Advisory group assesses vaccines by Sinopharm and Sinovac Biotech ahead of their evaluation for WHO emergency authorisation
- Concern that not enough data is available about effects of these vaccines on elderly and medically vulnerable patients
Vaccines by Chinese firms Sinovac Biotech and Sinopharm are being evaluated by the WHO for emergency-use licensing. A decision is expected this week. Photo: Xinhua
